Ogkologos | Ogkologos.com | Page 21

Home Authors Posts by Ogkologos

4396 POSTS 0 COMMENTS

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and...

Ogkologos - April 14, 2026

OS Advantage of Gotistobart Over Docetaxel in Patients with anti-PD‑(L)1- and...

Ogkologos - April 14, 2026

Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated...

Ogkologos - April 13, 2026

EMA Recommends Granting a Marketing Authorisation for Poherdy

Ogkologos - April 10, 2026

Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with...

Ogkologos - April 9, 2026

FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube,...

Ogkologos - April 8, 2026

Efficacy of Pembrolizumab and Olaparib Combination Observed in a Subset of Patients with HRD Metastatic Pancreatic Cancer

Ogkologos - April 7, 2026

Nomination Process for the 2026 ESMO Society Awards Now Open

Ogkologos - April 7, 2026

EMA Recommends Extension of Therapeutic Indications for Asciminib

Ogkologos - April 3, 2026

NHS England Lung Cancer Screening Programme Demonstrates that it is Feasible and Scalable...

Ogkologos - April 3, 2026

1...202122...440 Page 21 of 440

MOST POPULAR

Optimistic targets aren’t enough – this is what we need to...

July 19, 2023

Neoadjuvant Nivolumab Plus Chemotherapy Improves OS Among Patients with Resectable NSCLC...

June 24, 2025

Two Drugs Work Together to Block ‘Master Regulator’ of Breast, Other...

September 4, 2018

Updated Oncogene-Addicted mNSCLC Living Guideline v1.3

February 26, 2026

HOT NEWS

How Decades of NCI Support Led to Groundbreaking Discoveries: The Story...

Genetic Testing for Bladder Cancer: What People With Cancer and Their...

EMA Recommends Extension of Therapeutic Indications for Cabozantinib

Diagnosed With Breast Cancer At 24, Her Biggest Fear Wasn’t Death...